Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

DuPont (DD) Warms Up To Q2: Another Earnings Beat Coming?

Published 07/20/2017, 10:56 PM
Updated 07/09/2023, 06:31 AM

DuPont (NYSE:DD) is gearing up to release its second-quarter 2017 results ahead of the bell on Jul 25.

The Delaware-based company kept its positive earnings surprise streak alive with a solid beat in first-quarter 2017, supported by higher sales, strong demand for new products and benefits of its cost-reduction actions.

Its adjusted earnings of $1.64 per share for the quarter, topped the Zacks Consensus Estimate of $1.38. Revenues rose 5% year over year to $7,743 million on higher volumes and pricing, surpassing the Zacks Consensus Estimate of $7,539 million. The company saw higher sales in most segments in the quarter, supported by improved demand in major markets and new product launches.

DuPont’s shares have rallied 24% over the past year, outperforming the 22.2% gain of the industry it belongs to.


DuPont has beaten the Zacks Consensus Estimate in all of the last four quarters with an average beat of 28.73%. Is the company poised for another winning quarter? Let's see how things are shaping up for this announcement.

Factors to Watch For

DuPont, in its first-quarter call, said that it expects earnings per share (on a reported basis) for first-half 2017 of around $2.42, a decline of roughly 5% from the prior year. The guidance includes an expected charge of about 32 cents per share mainly related to the planned mega-merger with Dow Chemical (NYSE:DOW) .

Adjusted earnings for the first half are expected to be roughly $2.90 per share, reflecting a roughly 16% year over year increase, mainly driven by higher sales. The expected increase in sales is due to the impact of the change in timing for seed deliveries, mostly related to the southern U.S. route-to-market change in Agriculture and strength in automotive markets.

DuPont's cost-saving and productivity measures should continue to lend support to its earnings in the June quarter. These initiatives are delivering cost savings through reduction of operating costs and productivity improvements across the board.

The company's 2016 restructuring program delivered net cost reductions of $750 million in 2016, surpassing the target of $730 million. DuPont said that productivity will remain one of its top priorities in 2017.

The company is also seeing favorable market traction for its new Leptra corn hybrids in Brazil and its latest crop protection product, Zorvec fungicide. It remains committed to introduce new higher-performing products to meet farmers’ needs. New products and continued healthy demand in key markets including automotive and electronics should support its second-quarter results.

However, DuPont is exposed to certain headwinds that could affect its June quarter results. While DuPont’s agriculture business posted healthy results in the first quarter, it is still faced with industry-wide challenges. Weak farm commodity prices, abundant seed and crop protection inventories and tight credit conditions are still affecting this major market.

Moreover, growers’ preference of soybeans over corn in North America is expected to have an unfavorable impact on earnings in the company’s agriculture business. Expected reduction in corn acres may also weigh on its agriculture sales.

Moreover, sales in the company’s nutrition & health business are expected to be affected by the impact of portfolio changes. This segment is expected to face challenging market conditions this year, especially in the Middle East and Latin America. DuPont also sees elevated product costs in its performance materials business for first-half 2017 due to raw material cost inflation in major feedstocks.

DuPont is moving forward with its proposed merger with Dow Chemical, which is expected to create significant synergies. The companies, last month, secured clearance from Canada's Competition Bureau for the merger after they agreed to sell certain assets and businesses. The companies also received the U.S. antitrust approval for the merger in June. Moreover, the European Commission conditionally approved the merger in Mar 2017.

The companies, last month, also noted that their boards have jointly commenced a comprehensive portfolio review aimed at capturing material value-enhancing opportunities. The board of the combined company is expected to assess the results of this review after the completion of the merger transaction.

The companies continue to work constructively with regulators in the remaining jurisdictions to obtain approval for the merger and continue to expect the closing of the merger to take place in Aug 2017. The merger is projected to deliver cost synergies of around $3 billion and growth synergies of roughly $1 billion. We expect DuPont to provide an update on the merger in its second-quarter call.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Earnings Whispers

Our proven model does not conclusively show that DuPont is likely to beat estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. This is not the case here as you will see below:

Zacks ESP: The Earnings ESP for DuPont is 0.00% as both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $1.29. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: DuPont currently carries a Zacks Rank #2, which when combined with a 0.00% ESP, makes surprise prediction difficult.

We caution against stocks with Zacks Ranks #4 and #5 (Sell-rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum.

Stocks That Warrant a Look

Here are some other companies in the basic materials space you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:

Westlake Chemical Corporation (NYSE:WLK) has an Earnings ESP of +5.04% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Chemours Company (NYSE:CC) has an Earnings ESP of +4.44% and a Zacks Rank #2.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report

Dow Chemical Company (The) (DOW): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

Westlake Chemical Corporation (WLK): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.